Literature DB >> 12712364

New approaches to augment fungal biotransformation.

Balajee Shanmugam1, Scott Luckman, Mia Summers, Valerie Bernan, Michael Greenstein.   

Abstract

The possibility of using solid supports and intermittent substrate feeding to manipulate biotransformation by fungi was examined, with amoxapine as a model compound. Cunninghamella elegans ATCC 8688a grown as free cells in six-well plates showed 7-hydroxyamoxapine as the major metabolite of amoxapine biotransformation. However, when cells were grown in the presence of activated carbon, N-formyl-7-hydroxyamoxapine was formed as the major metabolite. Intermittent feeding of amoxapine also favored the formation of N-formyl-7-hydroxyamoxapine.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12712364     DOI: 10.1007/s10295-003-0052-2

Source DB:  PubMed          Journal:  J Ind Microbiol Biotechnol        ISSN: 1367-5435            Impact factor:   3.346


  7 in total

1.  A rapid and efficient method for growth measurement of filamentous fungi.

Authors:  F Langvad
Journal:  J Microbiol Methods       Date:  1999-07       Impact factor: 2.363

Review 2.  Growth of filamentous fungi in submerged culture: problems and possible solutions.

Authors:  P A Gibbs; R J Seviour; F Schmid
Journal:  Crit Rev Biotechnol       Date:  2000       Impact factor: 8.429

3.  A convenient fluorometric method for the detection of extracellular N-acetylglucosaminidase production by filamentous fungi.

Authors:  C Omero; B A Horwitz; I Chet
Journal:  J Microbiol Methods       Date:  2001-01       Impact factor: 2.363

4.  Transformation of amoxapine by Cunninghamella elegans.

Authors:  J D Moody; D Zhang; T M Heinze; C E Cerniglia
Journal:  Appl Environ Microbiol       Date:  2000-08       Impact factor: 4.792

5.  Implementation of a rapid microbial screening procedure for biotransformation activities.

Authors:  S Stahl; R Greasham; M Chartrain
Journal:  J Biosci Bioeng       Date:  2000       Impact factor: 2.894

6.  The use of microscale processing technologies for quantification of biocatalytic Baeyer-Villiger oxidation kinetics.

Authors:  Steven D Doig; Samuel C R Pickering; Gary J Lye; John M Woodley
Journal:  Biotechnol Bioeng       Date:  2002-10-05       Impact factor: 4.530

7.  Reactor operation and scale-up of whole cell Baeyer-Villiger catalyzed lactone synthesis.

Authors:  Steven D Doig; Philip J Avenell; Paul A Bird; Patrick Gallati; Katie S Lander; Gary J Lye; Roland Wohlgemuth; John M Woodley
Journal:  Biotechnol Prog       Date:  2002 Sep-Oct
  7 in total
  2 in total

1.  Production of drug metabolites by immobilised Cunninghamella elegans: from screening to scale up.

Authors:  Laura Quinn; Rita Dempsey; Eoin Casey; Ayla Kane; Cormac D Murphy
Journal:  J Ind Microbiol Biotechnol       Date:  2015-02-10       Impact factor: 3.346

2.  Enhanced biotransformation of fluoranthene by intertidally derived Cunninghamella elegans under biofilm-based and niche-mimicking conditions.

Authors:  Sayani Mitra; Arnab Pramanik; Srijoni Banerjee; Saubhik Haldar; Ratan Gachhui; Joydeep Mukherjee
Journal:  Appl Environ Microbiol       Date:  2013-09-13       Impact factor: 4.792

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.